You may have to Search all our reviewed books and magazines, click the sign up button below to create a free account.
Biology of Female Cancers explores what can be learned about female cancers by summarizing what is known about the mechanisms of growth regulation and genetic features associated with common forms of female cancers, including malignancies of the breast, ovary, uterus, cervix, vulva, and gestational trophoblastic disease. The book describes the etiology, incidence, pathology, staging, and treatment of each type of cancer. The risk of developing particular tumor types and how their growth may be influenced by hormones, growth factors, and cytokines is also discussed. For oncologists, gynecologists and obstetricians, cell biologists, and everyone interested in learning more about female cancers, the Biology of Female Cancers offers a comprehensive, unique approach.
Long considered the bible of thoracic surgery, this comprehensive text guides readers through open and endoscopic surgical techniques with expert commentary by the leaders in thoracic surgery. Coverage includes extensive sections on lung cancer and other pulmonary tumors. Includes access to a companion Web site.
In 74 chapters, Gastrointestinal Oncology brings together a diverse group of specialists to provide the most authoritative, up-to-date and encyclopedic volume currently available on the subject. The first part of this text introduces a series of concepts and topics taht are important to gastrointestinal malignancies in general. These topics include epidemiologic principles, prevention, screening, familial GI cancers, developmental and molecular biology, pathobiology, general therapeutic principles, emerging therapies, and palliative care. The second part of the book covers each of the specific cancers affecting the human gastrointestinal tract. These chapters are introduced by state of the art discussions outlining our current understanding of the pathobiology and molecular biology relevant to each cancer. Subsequent sections describe the multidisciplinary management of specific clinical situations. By organizing the treatment-related chapters around clinical scenarios, the reader will readily find the information necessary to effectively manage the complex clinical situations encountered by patients with gastrointestinal malignancies.
This updated Fourth Edition provides comprehensive coverage of the biology of gynecologic cancer, the therapeutic modalities available, and the diagnosis and treatment of site-specific malignancies. Because of the importance of multimodality treatment, the site-specific chapters are co-authored by a surgical oncologist, a medical oncologist, a radiation oncologist, and a pathologist. A significant portion of this edition focuses on monoclonal antibodies, vaccines, and gene directed therapies and how they can greatly improve treatment outcomes. A new chapter on end-of-life care is also included. Three distinguished new editors—Richard R. Barakat, MD, Maurie Markman, MD, and Marcus E. Randall, MD—now join the editorial team.
None
Corrections to / computational errors in v.1 listed in: v.2, p. 388; "Errors in v.2" listed in : v. 3, p. 558.
A multi-authored, clinical work describing the controversies in the management of the difficult problem of ovarian cancer, and offering individual views and recommendations of the experts followed by commentary from the editors. The editors have chosen a panel format as a novel approach to assisting the gynaecologist and oncologist in management. Addresses difficult problems of ovarian cancer management and detection Provides specific and personal guidance from the experts Comments on the book proposal include: David Gershenson is an extremely well respected gynecologic oncologist and surgeon who has edited a major gynecologic surgery text for WB Saunders. The MD Anderson Cancer Center is one of the premier cancer institutes internationally. William P. McGuire was instrumental in the launch of the important drug taxol and is a leader in the medical oncology field.""